DISHMAN CARBOGEN AMCIS
Quarterly Results Analysis [Dec2023]
DISHMAN CARBOGEN AMCIS Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹651 Cr | ₹587 Cr | ₹723 Cr | ₹619 Cr | ₹640 Cr | ₹614 Cr | ₹541 Cr | ₹569 Cr |
Expenses | ₹610 Cr | ₹526 Cr | ₹602 Cr | ₹567 Cr | ₹526 Cr | ₹535 Cr | ₹452 Cr | ₹547 Cr |
Operating Income | ₹41 Cr | ₹61 Cr | ₹122 Cr | ₹51 Cr | ₹114 Cr | ₹79 Cr | ₹88 Cr | ₹22 Cr |
Other Income | ₹6 Cr | ₹8 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr | ₹9 Cr | ₹6 Cr | ₹4 Cr |
Interest | ₹33 Cr | ₹27 Cr | ₹28 Cr | ₹24 Cr | ₹22 Cr | ₹20 Cr | ₹19 Cr | ₹16 Cr |
Depreciation | ₹80 Cr | ₹75 Cr | ₹70 Cr | ₹76 Cr | ₹50 Cr | ₹80 Cr | ₹75 Cr | ₹84 Cr |
Profit Before Tax | ₹-66 Cr | ₹-36 Cr | ₹29 Cr | ₹-88 Cr | ₹46 Cr | ₹-12 Cr | ₹0 Cr | ₹-85 Cr |
Profit After Tax | ₹-60 Cr | ₹-41 Cr | ₹17 Cr | ₹-71 Cr | ₹47 Cr | ₹-10 Cr | ₹4 Cr | ₹-45 Cr |
EPS | ₹-3.80 | ₹-2.61 | ₹1.08 | ₹-4.51 | ₹2.99 | ₹-0.64 | ₹0.26 | ₹-2.85 |
Industry Peers & Returns | 1W | 1M | 1Y |
DISHMAN CARBOGEN AMCIS | 1.9% | -10.1% | 69.3% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
DISHMAN CARBOGEN AMCIS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 11.00 % |
Y-o-Y | 1.77 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹651 Cr | 11.00 | |
Sep2023 | ₹587 Cr | -18.91 | |
Jun2023 | ₹723 Cr | 16.95 | |
Mar2023 | ₹619 Cr | -3.32 | |
Dec2022 | ₹640 Cr | 4.21 | |
Sep2022 | ₹614 Cr | 13.57 | |
Jun2022 | ₹541 Cr | -4.99 | |
Mar2022 | ₹569 Cr | - |
DISHMAN CARBOGEN AMCIS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -32.44 % |
Y-o-Y | -63.90 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹41 Cr | -32.44 | |
Sep2023 | ₹61 Cr | -50.07 | |
Jun2023 | ₹122 Cr | 136.90 | |
Mar2023 | ₹51 Cr | -54.83 | |
Dec2022 | ₹114 Cr | 44.87 | |
Sep2022 | ₹79 Cr | -10.98 | |
Jun2022 | ₹88 Cr | 301.50 | |
Mar2022 | ₹22 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -39.15 % |
Y-o-Y | -64.55 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 6.31% | -39.15 | |
Sep2023 | 10.37% | -38.46 | |
Jun2023 | 16.85% | 102.52 | |
Mar2023 | 8.32% | -53.26 | |
Dec2022 | 17.8% | 39.06 | |
Sep2022 | 12.8% | -21.62 | |
Jun2022 | 16.33% | 323.06 | |
Mar2022 | 3.86% | - |
DISHMAN CARBOGEN AMCIS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹-60 Cr | Negative | |
Sep2023 | ₹-41 Cr | Negative | |
Jun2023 | ₹17 Cr | Positive | |
Mar2023 | ₹-71 Cr | Negative | |
Dec2022 | ₹47 Cr | Positive | |
Sep2022 | ₹-10 Cr | Negative | |
Jun2022 | ₹4 Cr | Positive | |
Mar2022 | ₹-45 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | -9.16 % | Negative | |
Sep2023 | -6.97 % | Negative | |
Jun2023 | 2.35 % | Positive | |
Mar2023 | -11.43 % | Negative | |
Dec2022 | 7.34 % | Positive | |
Sep2022 | -1.64 % | Negative | |
Jun2022 | 0.74 % | Positive | |
Mar2022 | -7.84 % | - |
DISHMAN CARBOGEN AMCIS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | Negative |
Y-o-Y | Negative |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹-3.8 | Negative | |
Sep2023 | ₹-2.61 | Negative | |
Jun2023 | ₹1.08 | Positive | |
Mar2023 | ₹-4.51 | Negative | |
Dec2022 | ₹2.99 | Positive | |
Sep2022 | ₹-0.64 | Negative | |
Jun2022 | ₹0.26 | Positive | |
Mar2022 | ₹-2.85 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD